Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Phys Chem Chem Phys ; 18(8): 5905-9, 2016 Feb 17.
Article in English | MEDLINE | ID: mdl-26856872

ABSTRACT

Liquid layers adhered to solid surfaces and that are in equilibrium with the vapor phase are common in printing, coating, and washing processes as well as in alveoli in lungs and in stomata in leaves. For such a liquid layer in equilibrium with the vapor it faces, it has been generally believed that, aside from liquid lumps, only a very thin layer of the liquid, i.e., with a thickness of only a few nanometers, is held onto the surface of the solid, and that this adhesion is due to van der Waals forces. A similar layer of water can remain on the surface of a wall of a microchannel after evaporation of bulk water creates a void in the channel, but the thickness of such a water layer has not yet been well characterized. Herein we showed such a water layer adhered to a microchannel wall to be 100 to 170 nm thick and stable against surface tension. The water layer thickness was measured using electron energy loss spectroscopy (EELS), and the water layer structure was characterized by using a quantitative nanoparticle counting technique. This thickness was found for channel gap heights ranging from 1 to 5 µm. Once formed, the water layers in the microchannel, when sealed, were stable for at least one week without any special care. Our results indicate that the water layer forms naturally and is closely associated only with the surface to which it adheres. Our study of naturally formed, stable water layers may shed light on topics from gas exchange in alveoli in biology to the post-wet-process control in the semiconductor industry. We anticipate our report to be a starting point for more detailed research and understanding of the microfluidics, mechanisms and applications of gas-liquid-solid systems.

2.
J Cell Sci ; 127(Pt 8): 1792-804, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24522183

ABSTRACT

Hutchinson-Gilford progeria syndrome (HGPS) is a human progeroid disease caused by a point mutation on the LMNA gene. We reported previously that the accumulation of the nuclear envelope protein SUN1 contributes to HGPS nuclear aberrancies. However, the mechanism by which interactions between mutant lamin A (also known as progerin or LAΔ50) and SUN1 produce HGPS cellular phenotypes requires further elucidation. Using light and electron microscopy, this study demonstrated that SUN1 contributes to progerin-elicited structural changes in the nuclear envelope and the endoplasmic reticulum (ER) network. We further identified two domains through which full-length lamin A associates with SUN1, and determined that the farnesylated cysteine within the CaaX motif of lamin A has a stronger affinity for SUN1 than does the lamin A region containing amino acids 607 to 656. Farnesylation of progerin enhanced its interaction with SUN1 and reduced SUN1 mobility, thereby promoting the aberrant recruitment of progerin to the ER membrane during postmitotic assembly of the nuclear envelope, resulting in the accumulation of SUN1 over consecutive cellular divisions. These results indicate that the dysregulated interaction of SUN1 and progerin in the ER during nuclear envelope reformation determines the progression of HGPS.


Subject(s)
Endoplasmic Reticulum/metabolism , Lamin Type A/metabolism , Membrane Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Nuclear Envelope/metabolism , Nuclear Proteins/metabolism , Progeria/pathology , Endoplasmic Reticulum/pathology , Fibroblasts/metabolism , HeLa Cells , Humans , Lamin Type A/genetics , Mitosis , Nuclear Envelope/pathology , Point Mutation , Prenylation , Progeria/genetics , Protein Precursors/metabolism , Protein Processing, Post-Translational , Protein Transport , Skin/pathology
3.
Anal Chem ; 84(15): 6312-6, 2012 Aug 07.
Article in English | MEDLINE | ID: mdl-22816618

ABSTRACT

Transmission electron microscopy (TEM) is a unique and powerful tool for observation of nanoparticles. However, due to the uneven spatial distribution of particles conventionally dried on copper grids, TEM is rarely employed to evaluate the spatial distribution of nanoparticles in aqueous solutions. Here, we present a microchip nanopipet with a narrow chamber width for sorting nanoparticles from blood and preventing the aggregation of the particles during the drying process, enabling quantitative analysis of their aggregation/agglomeration states and the particle concentration in aqueous solutions. This microchip is adaptable to all commercial TEM holders. Such a nanopipet proves to be a simple and convenient sampling device for TEM image-based quantitative characterization.


Subject(s)
Microscopy, Electron, Transmission , Nanoparticles/analysis , Gold/chemistry , Humans , Lab-On-A-Chip Devices , Nanotechnology/instrumentation , Plasma/chemistry , Polyethylene Glycols/chemistry
4.
Microsc Res Tech ; 74(6): 531-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20967833

ABSTRACT

Gold nanoparticles (AuNPs) confined in liposomes of diameters around 200 nm produce strong scattering signal owing to surface plasmon resonance, and therefore bright-field optical tracking of the AuNP-encapsulating liposomes can be conducted in living cells. Using an optical profiling technique called noninterferometric wide-field optical profilometry and a bright-field tracking algorithm, the polynomial-fit Gaussian weight method, we analyze three-dimensional (3D) motion of such liposomes in living fibroblasts. The positioning accuracy in three dimensions is nearly 20 nm. We tag the liposome membranes with fibroblast growth factor-1 and reveal the intracellular transportation processes toward or away from the nucleus. On the basis of a temporal analysis of the intracellular 3D trajectories of AuNP-encapsulating liposomes, we identify directed and diffusive motions in the transportation processes.


Subject(s)
Cytological Techniques/methods , Liposomes/metabolism , Microscopy/methods , Time-Lapse Imaging/methods , Animals , Cells, Cultured , Fibroblasts/cytology , Fibroblasts/metabolism , Gold/chemistry , Imaging, Three-Dimensional , Liposomes/chemistry , Mice , Nanoparticles/chemistry , Staining and Labeling/methods
5.
J Hazard Mater ; 183(1-3): 182-8, 2010 Nov 15.
Article in English | MEDLINE | ID: mdl-20674161

ABSTRACT

This study investigated inflammatory effects of zinc oxide (ZnO) particles on vascular endothelial cells. The effects of 50 and 100-nm ZnO particles on human umbilical vein endothelial cells (HUVECs) were characterized by assaying cytotoxicity, cell proliferation, and glutathione levels. A marked drop in survival rate was observed when ZnO concentration was increased to 45 µg/ml. ZnO concentrations of ≤3 µg/ml resulted in increased cell proliferation, while those of ≤45 µg/ml caused dose-dependent increases in oxidized glutathione levels. Treatments with ZnO concentrations ≤45 µg/ml were performed to determine the expression of intercellular adhesion molecule-1 (ICAM-1) protein, an indicator of vascular endothelium inflammation, revealing that ZnO particles induced a dose-dependent increase in ICAM-1 expression and marked increases in NF-κB reporter activity. Overexpression of IκBα completely inhibited ZnO-induced ICAM-1 expression, suggesting NF-κB plays a pivotal role in regulation of ZnO-induced inflammation in HUVECs. Additionally, TNF-α, a typical inflammatory cytokine, induced ICAM-1 expression in an NF-κB-dependent manner, and ZnO synergistically enhanced TNF-α-induced ICAM-1 expression. Both 50 and 100-nm ZnO particles agglomerated to similar size distributions. This study reveals an important role for ZnO in modulating inflammatory responses of vascular endothelial cells via NF-κB signaling, which could have important implications for treatments of vascular disease.


Subject(s)
Endothelial Cells/pathology , Inflammation/chemically induced , NF-kappa B/metabolism , Signal Transduction/drug effects , Zinc Oxide/pharmacology , Cell Death , Cell Proliferation , Cells, Cultured , Dose-Response Relationship, Drug , Endothelial Cells/drug effects , Glutathione/analysis , Humans , Intercellular Adhesion Molecule-1/analysis , Nanoparticles , Signal Transduction/immunology
6.
Nitric Oxide ; 23(1): 60-4, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20399280

ABSTRACT

Zwitterionic diazeniumdiolate, a nitric oxide precursor, was dissolved in basic buffer solution (pH=9.0) and encapsulated in thermo-sensitive liposomes composed of phospholipids of different sensitive temperatures. The basic intra-liposomal environment dramatically delayed spontaneous NO release. When the liposomes were placed in physiological buffer solution and temperatures were increased to the sensitive temperatures of the phospholipids' membranes, extra-liposomal protons started to influx to collapse the pH gradient and subsequently induce a significant NO release. Moreover, the presence of a stronger pH gradient when the liposomes were applied to a more acidic environment caused a higher proton influx driving force to trigger the influx of protons and, subsequently, NO release. In this work, we demonstrate that thermo-sensitive liposomes can be used to create a stable pH gradient in a nanoenvironment entrapping zwitterionic diazeniumdiolate for sustained and heat/acid-activated NO release.


Subject(s)
Azo Compounds/chemistry , Liposomes/chemistry , Nitric Oxide Donors/chemistry , Nitric Oxide/chemistry , Azo Compounds/metabolism , Drug Delivery Systems , Hot Temperature , Hydrogen-Ion Concentration , Liposomes/metabolism , Nitric Oxide/pharmacokinetics , Nitric Oxide Donors/pharmacokinetics
7.
Nanotechnology ; 20(13): 135101, 2009 Apr 01.
Article in English | MEDLINE | ID: mdl-19420485

ABSTRACT

Iron oxide nanoparticles can serve as a heating source upon alternative magnetic field (AMF) exposure. Iron oxide nanoparticles can be mixed with thermosensitive nanovehicles for hyperthermia-induced drug release, yet such a design and mechanism may not be suitable for controllable drug release applications in which the tissues are susceptible to environmental temperature change such as brain tissue. In the present study, iron oxide nanoparticles were entrapped inside of thermosensitive liposomes for AMF-induced drug release while the environmental temperature was maintained at a constant level. Carboxyfluorescein was co-entrapped with the iron oxide nanoparticles in the liposomes as a model compound for monitoring drug release and environmental temperature was maintained with a water circulator jacket. These experiments have been successfully performed in solution, in phantom and in anesthetized animals. Furthermore, the thermosensitive liposomes were administered into rat forearm skeletal muscle, and the release of carboxylfluorescein triggered by the external alternative magnetic field was monitored by an implanted microdialysis perfusion probe with an on-line laser-induced fluorescence detector. In the future such a device could be applied to simultaneous magnetic resonance imaging and non-invasive drug release in temperature-sensitive applications.


Subject(s)
Delayed-Action Preparations/chemistry , Ferric Compounds/chemistry , Liposomes/chemistry , Metal Nanoparticles/chemistry , Animals , Electromagnetic Fields , Equipment Design , Fluoresceins/chemistry , Metal Nanoparticles/ultrastructure , Microscopy, Electron, Transmission , Rats , Temperature
8.
Biomaterials ; 30(22): 3645-51, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19359036

ABSTRACT

Superparamagnetic iron oxide (SPIO) nanoparticles are very useful in cell imaging; meanwhile, however, biosafety concerns associated with their use, especially on therapeutic stem cells, have arisen. Most studies of biosafety issues focus on whether the nanoparticles have deleterious effects. Here, we report that Ferucarbotran, an ionic SPIO, is not toxic to human mesenchymal stem cells (hMSCs) under the conditions of these experiments but instead increases cell growth. Ferucarbotran-promoted cell growth is due to its ability to diminish intracellular H2O2 through intrinsic peroxidase-like activity. Also, Ferucarbotran can accelerate cell cycle progression, which may be mediated by the free iron (Fe) released from lysosomal degradation and involves the alteration of Fe on the expression of the protein regulators of the cell cycle.


Subject(s)
Cell Proliferation/drug effects , Ferric Compounds/pharmacology , Iron/pharmacology , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/physiology , Nanoparticles/chemistry , Oxides/pharmacology , Animals , Cell Cycle/physiology , Contrast Media/chemistry , Contrast Media/pharmacology , Dextrans , Ferric Compounds/chemistry , Ferrosoferric Oxide , Humans , Hydrogen Peroxide/metabolism , Iron/chemistry , Magnetic Resonance Imaging , Magnetics , Magnetite Nanoparticles , Materials Testing , Mesenchymal Stem Cells/cytology , Oxidants/metabolism , Oxidation-Reduction , Oxides/chemistry , Peroxidases/metabolism
9.
Biochemistry ; 43(16): 4869-76, 2004 Apr 27.
Article in English | MEDLINE | ID: mdl-15096056

ABSTRACT

Xanthine oxidase (XOD) consists of two identical subunits. For the past 50 years or so, it was assumed that the two subunits carry out catalysis independently. Herein, we report that the presence of 6-formylpterin (6FP) or other substrates (such as xanthine or xanthopterin) at one of the two active sites affects the binding affinity and catalysis rate of 6FP at the other. When the two XOD active sites were occupied by two 6FPs simultaneously, the conversion rate (2.8 x 10(-3) s(-1)) of 6FP to 6CP is 2.95-fold faster than the conversion rate (0.95 x 10(-3) s(-1)) in the case of single 6FP bound condition. The presence of xanthine can accelerate the catalysis rate of 6FP by XOD as well as the activity-recovering rate of alloxanthine-inhibited XOD. Our experimental observations demonstrate unambiguously that the two XOD subunits are strongly cooperative in both binding and catalysis. The inhibition constant (Ki) of 6FP toward XOD was measured by a stopped-flow method to be 0.94 nM.


Subject(s)
Protein Subunits/chemistry , Protein Subunits/metabolism , Xanthine Oxidase/chemistry , Xanthine Oxidase/metabolism , Binding Sites , Catalysis , Dimerization , Enzyme Inhibitors/chemistry , Kinetics , Models, Chemical , Protein Subunits/antagonists & inhibitors , Pterins/chemistry , Pterins/metabolism , Spectrophotometry , Substrate Specificity , Xanthine Oxidase/antagonists & inhibitors
10.
Angew Chem Int Ed Engl ; 39(21): 3886-3888, 2000 Nov 03.
Article in English | MEDLINE | ID: mdl-29711699
SELECTION OF CITATIONS
SEARCH DETAIL
...